KFA
IBB icon

Kabarec Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Kabarec Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-18
Closed -$2K – 87
2018
Q1 		$2K Buy
+18
New +$2K ﹤0.01% 88

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kabarec Financial Advisors's IBB Position: Q2 2018 in Review

Kabarec Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 18 shares — an estimated $2K sold.

Kabarec Financial Advisors first reported a position in IBB in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

  • Kabarec Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
  • Kabarec Financial Advisors sold 18 iShares Biotechnology ETF shares in Q2 2018, an estimated $2K.
  • Kabarec Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 1 quarter.
  • Kabarec Financial Advisors's iShares Biotechnology ETF position peaked at $2K in Q1 2018.
  • 609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Kabarec Financial Advisors's 13F filing for Q2 2018, filed 9 Aug 2018.